See every side of every news story
Published loading...Updated

This Antidepressant Recalled in France Due to Impurities Classified as Carcinogens

The Medicine Agency has announced that this antidepressant, prescribed to 5,000 patients in France, including a majority of seniors, will be withdrawn from the market by the end of 2026 due to its composition.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Left

The Medicine Agency has announced that this antidepressant, prescribed to 5,000 patients in France, including a majority of seniors, will be withdrawn from the market by the end of 2026 due to its composition.

·Paris, France
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Le Huffington Post broke the news in Paris, France on Wednesday, July 30, 2025.
Sources are mostly out of (0)